Raffaele Ratta

3PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 24, 2022
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.

Elodie Dang, Alexandre Vallée, Coralie Lepage-Seydoux

|Jun 08, 2021
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.

Daniel P Petrylak, Raffaele Ratta, Rustem Gafanov

|May 06, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic review.

Raffaele Ratta, Annalisa Guida, Florian Scotté

Pageof 1